Enabling every cure for community matters: Our AI-powered journey
As we move through 2024, I’m thrilled with the extraordinary work our team is doing to change how we finance drug development: from funding next-generation therapies to helping others identify the highest potential cures in their development pipelines.
Revolutionizing Drug Development for Rare Diseases Through AI | Alok Tayi
“In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.”
Developing a Small Molecule for Duchenne Muscular Dystrophy with Frank Gleeson | VibeCast Episode 48
In this episode, VibeCast host Ray Dogum speaks with Frank Gleeson, Co-Founder and CEO of Satellos Bioscience, about groundbreaking small molecule therapies for Duchenne muscular dystrophy. Frank Gleeson’s journey into the world of small molecule therapy for Duchenne muscular dystrophy is a testament to the power of unexpected paths and unwavering determination. Growing up with […]
The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio
Watch the 3 part podcast episode on YouTube! We are proud to share a recent The Biotech Startups Podcast episode hosted by Jon Chee, CEO of Excedr. In the episode, Jon and Alok discuss the many opportunities that can improve the biotech industry and how Vibe Bio is tackling the problem of funding & guiding […]
Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands
John Cumbers authored an article featuring Alok Tayi’s new start-up, Vibe Bio. “In short, the contours of drug development are defined around inflection points — the kinds of milestones that serve as “power-ups” to move a company to the next level of funding and scientific research by increasing a company’s valuation and strategically informing what […]
